Position in SIBN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$6,648,164
+$1,241,754 QoQ
Shares Held
407,363
-4.8% QoQ
Ownership
0.909%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#27
of 168 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in SIBN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $99,066,369 across 10 Medical Devices names. SIBN ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
664,581 | $44,759,530 | |
| 2 | IRTC |
iRhythm Holdings, Inc.
|
75,724 | $9,007,369 | |
| 3 | BRKR |
Bruker Corp
|
116,687 | $7,022,223 | |
| 4 | SIBN |
SI-BONE, Inc.
This page
|
407,363 | $6,648,164 | |
| 5 | CBLL |
Ceribell, Inc.
|
331,413 | $6,445,982 | |
| 6 | LIVN |
LivaNova PLC
|
73,484 | $6,042,589 | |
| 7 | PRCT |
PROCEPT BioRobotics Corp
|
251,296 | $5,674,263 | |
| 8 | HAE |
Haemonetics Corp
|
59,966 | $4,497,450 |
All Filings in SIBN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,648,164 | 407,363 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $5,406,410 | 428,061 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,469,758 | 378,791 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,649,271 | 383,782 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $6,664,387 | 354,112 | Shares | Sole | 2025-08-01 | |
| No filing history on record for this holder in this stock. | ||||||